From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is a prevalent chronic liver disease worldwide, affecting more than 30% of the global population (1Rinella M.E. Neuschwander-Tetri B.A. Siddiqui M.S. Abdelmalek M.F. Caldwell S. Barb D. Kleiner D.E. Loomba R. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.Hepatology. 2023; 77: 1797-1835Crossref PubMed Scopus (173) Google Scholar, 2Yip T.C. Vilar-Gomez E. Petta S. Yilmaz Y. Wong G.L. Adams L.A. de L.,V. Sookoian S. Wong V.W. Geographical similarity and differences in the burden and genetic predisposition of NAFLD.Hepatology. 2023;…